Purpose To evaluate the efficacy of adjuvant systemic chemotherapy for locally advanced
(pT3-4pN0/xM0) upper tract urothelial carcinoma (UTUC). Materials and methods We …

Background Radical nephroureterectomy (RNU) is the primary treatment strategy for upper
tract urothelial carcinoma (UTUC). However, the intravesical recurrence occurs in 20–50 …

Purpose This study aimed to evaluate the trend of adjuvant chemotherapy (AC) and
neoadjuvant chemotherapy (NAC) in patients who underwent radical nephroureterectomy …

Background No definitive evidence exists regarding use of adjuvant chemotherapy (AC) for
high-risk cases after radical nephroureterectomy (RNU), and the benefit of AC remains …

Purpose The aim of this retrospective study was to evaluate the efficacy of adjuvant cisplatin-
based chemotherapy in patients with locally-advanced upper tract urothelial carcinoma …

OBJECTIVES: Urothelial carcinoma of the renal pelvis and ureter is a relatively uncommon
malignancy. The majority of patients present at a stage in which disease has not penetrated …

Objectives Upper-tract urothelial carcinoma (UTUC) is associated with poor outcomes. Our
aim was to assess adequacy of renal function and evaluate the role of adjuvant …

The management of patients with upper tract urothelial carcinoma (UTUC) is challenging
due to the lack of high-level evidence, which results from the disease's overall rarity. The …

Objective: To determine whether adjuvant chemotherapy (ACH) influences cancer-specific
mortality, bladder cancer-specific mortality, and other-cause mortality in patients with locally …

Objective: To evaluate the efficacy of adjuvant cisplatin-based chemotherapy for locally
advanced upper tract urothelial cell carcinoma (UTUC) following radical …